Variations in the expression of the expanded DMPK transgene, relative to MBNL, CELF, and other RNA-binding proteins may account for the distinct transcriptome responses to the DM1 expansion, and require further investigation. This evidence concerns the gene CEBPD and myotonic dystrophy type 1.